CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![digital-biomarkers-GettyImages-2246115813]( "How Pharmacometrics Informs Dose Selection And Biomarker Decisions")
How Pharmacometrics Informs Dose Selection And Biomarker DecisionsQuantitative modeling informs dose selection and biomarker insights early, reducing uncertainty, improving study design, and enabling faster, more confident decisions from first trials to clinical progress.
-
![clinical-trials-cros-GettyImages-1346675527]( "Anthropic's Stainless Acquisition: What It Means For Clinical Trials")
Anthropic's Stainless Acquisition: What It Means For Clinical TrialsAs AI models become interchangeable, value is shifting to the orchestration layer that connects tools, workflows, and governance—making flexibility, interoperability, and auditability critical.
-
![ai-data-GettyImages-2236890597]( "Don't Just Swap The Engine. Redesign The Factory.")
Don't Just Swap The Engine. Redesign The Factory.Discover how AI-native technology is accelerating study startup, streamlining operations, and helping sponsors and CROs deliver therapies to patients faster.
-
![GettyImages-1226888991 oncology data]( "What Is Ontology? Learn About The Data Layer That Makes Agentic AI Work")
What Is Ontology? Learn About The Data Layer That Makes Agentic AI WorkGet an overview of ontology, the "semantic translator" that determines whether your AI investments actually compound or stay forever siloed.
-
![agenic-ai-GettyImages-2195607659]( "Early-Stage Biotech's AI Advantage Is A Window That Closes")
Early-Stage Biotech's AI Advantage Is A Window That ClosesFDA AI guidance won’t build your strategy for you. Learn how biotech teams can avoid retrofits and design smarter clinical AI from day one.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Accelerating Enrollment And Upholding Quality In Complex Oncology Trials5/5/2026
Real-world oncology trials reveal how fast physician engagement, hands-on biomarker management, and adaptive enrollment shorten timelines, reach first-patient milestones, and preserve data quality.
-
Scaling Global Vaccine Mega-Trials For A Top Five Pharma4/16/2026
See how high-volume enrollment, dynamic safety data capture, and rapid iteration can support global studies operating under intense timelines and scale.
-
Increasing Participation In World-Class Cancer Research In Northwest Arkansas3/26/2026
Discover how data automation and integrated screening help community cancer centers offer clinical research as a standard care option, ensuring all patients have access to the latest treatments.
-
Improving Clinical Research Efficiency And Access For Underserved Populations3/26/2026
Modernizing data workflows removes geographic barriers to clinical trials, ensuring rural patients access innovative care while reducing administrative burdens on dedicated research staff.
-
Changing The Clinical Feasibility Game With AI1/22/2026
AI is only as good as the data it’s built upon. Our customized AI platforms are constructed on a foundation of trustworthy, carefully curated data to produce detailed, expert-driven responses.
CENTRAL LABORATORIES PRODUCTS & SERVICES
Enable secure, flexible data exchange with open REST integrations—streamlining workflows, reducing manual effort, and supporting modern, audit‑ready clinical operations.
It’s about time.
Modern ePRO/eCOA.
Solved.
Don’t wait a lifetime to launch a study that’s just “good enough”. Build and design a data collection experience that patients and sites will love to use.
Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.
At Ideagen, we're committed to empowering seamless collaboration and enhancing your document review process. Through strategic alliances with leading technology providers across the life science industry, we offer integrations that amplify the efficiency and effectiveness of your workflows.
Code and approve clinical trial data from any device and keep your safety and efficacy data clean, consistent, and ready for analysis.
Zelta’s EDC has been used in more than 4,000 studies from startup to submission, across all phases, including over 500 phase 3c trials and 23 therapeutic areas.
The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.
Seamlessly integrated with Curebase’s ePRO/eCOA suite, our EDC enables hybrid and site-based studies that users will love and that streamline all of your data collection into a single, modern experience.
CENTRAL LABORATORIES SOLUTIONS
- Accelerate Approval Of Novel Therapies
- Clinical Data Studio: Unlock The True Power Of Clinical Trial Data
- Drive Patient Enrollments With Data-Powered Recruitment Engine
- A Simplified, Accessible Solution For Phase I And Phase IV Trials
- Data-Powered Financial Management For Your Clinical Trials
- Informed Diversity Action Planning Made Simple
- Oncology Solutions
- Synthetic Control Arm®: The Smart External Control Arm Solution
- Drive Automation And Efficiency In Your Interim Lock Process
- Unified Clinical Trial Platform Delivering Patient, Data, And Study Experiences
VIDEOS
NEWS
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework
- ISPOR Announces New Executive Director
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials
- Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®
- Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer
- AI Agent Enhances Principal Investigator Oversight Of eCOA Data
- Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
- Univo IRB And The Patient View Announce Partnership
- Avance Clinical Launches Diversity In STEM Scholarships Across Australia And North America
- Lindus Health And Quotient Sciences Partner To Accelerate Drug Development From First-In-Human To Pivotal Trials
- Integrating Lyft Healthcare As An Affordable On-Demand Transportation Provider For Clinical Trial Participants: A Move Towards Enhanced Patient Experience
- Yoncare s.r.o. Partners With Block Clinical Inc. To Deliver EU-Centric Clinical Trial Participant Travel And Payment Services In Europe
- Block Clinical Discusses Patient Travel Support With Panel Members
- Quotient Sciences And Intrepid Labs Form Strategic Partnership To Accelerate AI-Guided Formulation Development